Boston Scientific Acquires EndoChoice

Boston Scientific (NYSE:BSX) has completed its acquisition of EndoChoice Holdings, the company announced today. EndoChoice is now part of Boston Scientific’s endoscopy division.
According to the press release:

“The two organizations announced a definitive agreement on September 27, 2016 for Boston Scientific to acquire the EndoChoice business at a cash price of $8.00 per share for an approximate total of $210 million.”

Art Butcher, the senior VP of Endoscopy at Boston Scientific, said the following:

“We are excited to provide physicians more comprehensive solutions to help assess, diagnose and treat patients with GI conditions. Boston Scientific is a leader in the field of endoscopy and we are committed to providing innovative products and services to meet the changing and growing needs within the field.”

Read the full press release here.